Phenylephrine, endothelin, prostaglandin F(2α), and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro

Endocrine

Volumn 9, Issue 1, 1998, Pages 45-55

  King, Kathleen L ^a   Winer, Jane ^a   Phillips, David M ^b   Quach, James ^a   Williams, P Mickey ^a   Mather, Jennie P ^a  

^a GENENTECH INC   (United States)

^b POPULATION COUNCIL   (United States)

Author keywords

Cardiac hypertrophy; Endothelin; Leukemia inhibitory factor; Phenylephrine; Prostaglandin F(2 )

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN; ISOPRENALINE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MYOSIN LIGHT CHAIN; PHENYLEPHRINE; PROSTAGLANDIN F2 ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART HYPERTROPHY; HEART MUSCLE CELL; IN VITRO STUDY; MUSCLE FIBRIL; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 0031722486     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:9:1:45     Document Type: Article

References (38)

1. Morkin, E. (1970). Science 167, 1499-1501.
2. Anversa, P., Olivetti, G., Melssari, M., and Loud, A. V. (1980). J. Mol. Cell. Cardiol. 12, 781-795.
3. Anversa, P., Levicky, V., Beghi, C., McDonald, S. L., and Kikkawa, Y. (1983). Circ. Res. 52, 57-64.
4. Gerdes, A. M., Campbell, S. E., and Hilbelink, D. R. (1988). Lab. Invest. 59, 857-861.
5. Simpson, P., McGrath, A., and Savion, S. (1982). Circ. Res. 51, 787-801.
6. Chien, K. R., Knowlton, K. U., Zhu, H., and Chien, S. (1991). FASEB J. 5, 3037-3046.
7. Glembotski, C. C., Irons, C. E., Krown, K. A., Murray, S. F., Sprenkle, A. B., and Sei, C. A. (1993). J. Biol. Chem. 27, 20,646-20,652.
8. Pennica, D., King, K.L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S.-M., et al. (1995). Proc. Nat. Acad. Sci. USA 92, 1142-1146.
9. Shubieta, H. E., McDonough, P. M., Harris, A. N., Knowlton, K. U., Glembotski, C. C., Brown, J. H., and Chien, K. R. (1990). J. Biol. Chem. 265, 20,555-20,562.
10. Ito, H., Hirata, Y., Hiroe, M., Tsujino, M., Adachi, S., Takamoto, T., et al. (1991). Circ. Res. 69, 209-215.
11. Suzuki, T., Hoshi, H., Sasaki, H., and Mitsui, Y. (1991) J. Cardiovasc. Pharmacol. 17(Suppl. 7), S182-S186.
12. King, K. L., Lai, J., Winer, J., Luis, E., Yen, R., Hooley, J., et al. (1996) Endocrine 5, 85-93.
13. Adams, J. W., Migita, D. S., Yu, M., Young, R., Hellickson, M. S., Castro-Vargas, F. E., et al. (1996). J. Biol. Chem. 271, 1179-1186.
14. Lai, J., Winer, J., Yen, R., Li, W., King, K. L., Jin, H., et al. (1996). Am. J. Physiol. 271, H2197-H2208.
15. Brodele, O.-E., Michel, M. C., and Zerkowski, H.-R. (1995). Cardiovasc. Res. 30, 570-584.
16. Gibson, U. E. M., Heid, C. A., and Williams, P. M. (1996). Genome Res. 6, 995-1001.
17. Rhee, D., Sanger, J. M., and Sanger J. W. (1994). Cell Motil. Cytoskel. 28, 1-24.
18. Forbes, M. S. and Sperelakis, N. (1989). In: Physiology and Pathophysiology of the Heart. Sperelakis, N. (ed.) Kluwer: Boston. pp. 3-41.
19. Sperelakis, N. and Lemkuhl, D. (1964). J. Gen. Physiol. 47, 895-927.
20. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., et al. (1991). J. Clin. Invest. 87, 1402-1412.
21. Nakao, K., Ogawa, Y., Suga, S., and Imura, H. (1992). J. Hypertension 10, 907-912.
22. Horio, T., Kohno, M., and Takeda, T. (1993). Metabolism 42, 94-96.
23. Nakagawa, O., Itoh, H., Harada, M., Komatsu, Y., Yoshimasa, T., and Nakao, K. (1995). Clin. Exp. Pharmacol. Physiol. Suppl. 1, S183-S185.
24. Wollert, K. C., Taga, T., Saito, M., Narazaki, M., Kishimoto, T., Glembotski, C. C., et al. (1996). J. Biol. Chem. 271, 9535-9545.
25. Boheler, K. R. and Schwartz K. (1992). TCM 2, 176-182.
26. Calderone, A., Takahashi, N., Izzo, N. J., Thaik, C. M., and Colucci, W.S. (1995). Circulation 92, 2385-2390.
27. Ito, H., Hiroe, M., Hirata, Y., Fujisaki, H., Adachi, S., Akimoto, H., et al. (1994). Circulation 89, 2198-2203.
28. Schwartz, K., de la Bastie, D., Bouveret, P., Oliviero, P., Alonso, S., and Buckingham, M. E. (1986). Circ. Res. 59, 551-555.
29. Izumo, S., Nadal-Ginard, B., and Mahdavi, V. (1988). Proc. Natl. Acad. Sci. USA 85, 339-343.
30. Boheler, K. R., Carrier, L., de la Bastle, D., Allen P. D., Komajda, M., Mercadier, J. J., et al. (1991). J. Clin. Invest. 88, 323-330.
31. Yorekane, R., Sakai, S., Miyauchi, T., Sakurai, T., and Goto, K. (1994). Arnzneimittel-Forschung 44, 412-415.
32. Moravic, C. S., Keller, E., and Bond, M. (1995). J. Mol. Cell. Cardiol. 27, 2101-2109.
33. Nishikimi, T., Yoshihara, F., Morimoto, A., Ishikawa, T., Saito, Y., Kangawa, K., et al. (1996). Hypertension 28, 22-30.
34. Bogoyevitch, M. A. and Sugden, P. H. (1996). Int. J. Biochem. Cell Biol. 28, 1-12.
35. Watanabe, T., Nakao, A., Emerling, D., Hashimoto, Y., Tsukamoto, K., Horie, Y., et al. (1994). J. Biol. Chem. 26, 17,619-17,625.
36. Boder, G. B., Harley, R. J., and Johnson, I. S. (1971). Nature 231, 531-532.
37. Heid, C. A., Stevens, J., Livak, K. J., and Williams, P. M. (1996). Genome Res. 6, 986-994.
38. Winer, J. and Williams, P. M. (1998) manuscript submitted.